<div id="readability-page-1"><p>Aveo Capital Partners LLC raised its holdings in  Oracle Corporation (NYSE:ORCL - Free Report) by 47.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,318 shares of the enterprise software provider's stock after buying an additional 1,061 shares during the quarter. Aveo Capital Partners LLC's holdings in Oracle were worth $496,000 as of its most recent SEC filing.</p><ul><li>Why Options Traders Are Betting Big on Oracle Stock </li></ul><p>Several other institutional investors have also recently added to or reduced their stakes in ORCL. Sunbeam Capital Management LLC bought a new position in shares of  Oracle in the 4th quarter worth $30,000.  Redmont Wealth Advisors LLC bought a new position in shares of  Oracle in the 1st quarter worth $27,000.  Inlight Wealth Management LLC bought a new position in shares of  Oracle in the 1st quarter worth $28,000.  Iron Horse Wealth Management LLC lifted its holdings in shares of  Oracle by 284.9% in the 1st quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock worth $29,000 after purchasing an additional 151 shares in the last quarter.  Finally, Mpwm Advisory Solutions LLC bought a new position in shares of  Oracle in the 4th quarter worth $36,000. 42.44% of the stock is owned by institutional investors and hedge funds. </p><h2>Insider Activity at Oracle</h2><p>In related news, EVP Maria Smith sold 10,000 shares of the company's stock in a transaction that occurred on Thursday, July 3rd. The stock was sold at an average price of $232.99, for a total transaction of $2,329,900.00. Following the completion of the transaction, the executive vice president owned 40,807 shares in the company, valued at $9,507,622.93. This represents a 19.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. Also, Director Naomi O. Seligman sold 3,303 shares of the stock in a transaction on Wednesday, July 16th. The stock was sold at an average price of $233.32, for a total value of $770,655.96. Following the completion of the transaction, the director owned 31,447 shares of the company's stock, valued at approximately $7,337,214.04. This trade represents a 9.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 444,183 shares of company stock valued at $86,521,198 over the last 90 days. Company insiders own  42.20% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><ul><li>This Fund Manager Says You Should Get Out of Tesla and Apple—Now</li></ul><p>A number of equities research analysts recently commented on ORCL shares. DA Davidson increased their price target on Oracle from $140.00 to $170.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, June 12th. Loop Capital  set a $135.00 price target on Oracle in a research report on Tuesday, June 10th. Stifel Nicolaus raised Oracle from a &#34;hold&#34; rating to a &#34;buy&#34; rating and increased their price target for the company from $180.00 to $250.00 in a research report on Monday, June 30th. JPMorgan Chase &amp; Co. increased their price target on Oracle from $135.00 to $185.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, June 12th. Finally, UBS Group increased their price target on Oracle from $250.00 to $280.00 and gave the company a &#34;buy&#34; rating in a research report on Thursday, July 17th. Nine equities research analysts have rated the stock with a hold rating, twenty-three have assigned  a buy rating and three have issued  a strong buy rating to the company's stock. According to MarketBeat.com, Oracle currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $222.75.</p><p><b>Read Our Latest Stock Analysis on Oracle</b></p><h2>Oracle Stock Performance</h2><ul><li>Palantir Gets Price Hike From Wedbush Amid High Valuation</li></ul><p>NYSE:ORCL opened at $250.04 on Friday. The business has a 50 day moving average of $222.64 and a 200 day moving average of $177.81. The company has a market capitalization of $702.32 billion, a price-to-earnings ratio of 57.61, a PEG ratio of 3.73 and a beta of 1.43. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $260.87. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75. </p><p>Oracle (NYSE:ORCL - Get Free Report) last released its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.06. The company had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. Oracle's quarterly revenue was up 11.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.  On average, sell-side analysts predict that  Oracle Corporation will post 5 earnings per share for the current fiscal year. </p><h2>Oracle Announces Dividend</h2><p>The firm also recently announced a quarterly dividend, which was paid on Thursday, July 24th. Investors of record on Thursday, July 10th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Thursday, July 10th. Oracle's dividend payout ratio  is currently 46.08%. </p><h2>About Oracle</h2> (Free Report)<p>Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.</p><h2>See Also</h2><ul><li>Five stocks we like better than Oracle</li><li>Growth Stocks: What They Are, Examples and How to Invest</li><li>Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact?</li><li>Where Do I Find 52-Week Highs and Lows?</li><li>Trump GLP-1 Pilot Program Could Boost Novo Nordisk &amp; Eli Lilly</li><li>Growth Investing: Should You Adopt This Investing Strategy in 2022?</li><li>Now Is a Great Time to Buy Cheniere Energy: New High Expected</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9SQ0w?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9SQ0w"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Oracle Right Now?</h2><p>Before you consider Oracle, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.</p><p>While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ORCL

<p>Aveo Capital Partners LLC increased its holdings in Oracle Corporation (NYSE:ORCL) by 47% in Q1, owning 3,318 shares valued at $496,000. Other institutional investors also adjusted their stakes in Oracle. Insider sales included EVP Maria Smith selling 10,000 shares and Director Naomi O. Seligman selling 3,303 shares. Analysts have raised price targets for Oracle, with a consensus rating of "Moderate Buy" and an average price target of $222.75. Oracle's stock opened at $250.04, with a market cap of $702.32 billion and a P/E ratio of 57.61.</p>

Aveo Capital Partners LLC Has $496,000 Holdings in Oracle Corporation (NYSE:ORCL)